
Third Party Medical Journal Articles
-
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 (1 May 2020)
-
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 (1 May 2020)
-
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 (1 May 2020)
-
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Markus Hoffmann, Hannah Kleine Weber, Simon Schroeder, et al. (5 March 2020)
-
Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics (25 February 2020)
-
Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 aftervascular balloon injury in rats (18 June 2013)
-
Renin–angiotensin system in human coronavirus pathogenesis (1 March 2010)
-
Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures (1 February 2010)